second generation ubiquitin specific protease 7 inhibitors (Progenra/Children’s Hospital of Philadelphia/UCONN Health)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesecond generation ubiquitin specific protease 7 inhibitors (Progenra/Children’s Hospital of Philadelphia/UCONN Health)
Drug Alias NameTreg modulator (Progenra)second generation USP-7 inhibitors (Progenra/Children’s Hospital of Philadelphia/UCONN Health)P-0217564P-218283P-217564
ClassificationSmall molecules
Mechanisms of ActionImmunostimulantsUbiquitin carboxyl-terminal hydrolase 7 inhibitorsApoptosis stimulants +[4] 
TargetsUbiquitin carboxyl-terminal hydrolase 7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProgenra Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProgenra IncUniversity Of Connecticut Health CenterUniversity Of Pennsylvania +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A